Ardelyx (ARDX) EBIT Margin (2013 - 2026)
Ardelyx posted quarterly EBIT Margin of 34.71% for Q1 2026, up 1433.0% year-on-year from 2.26% in Q1 2025, and down 952.4% on a QoQ basis from 4.07% in Q4 2025.
Ardelyx (ARDX) has 12 years of EBIT Margin data on file, last reported at 34.71% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 1433.0% year-over-year to 34.71%; the trailing twelve-month figure through Mar 2026 stood at 11.67% (down 71.0% YoY), and the FY2025 full-year result was 10.06%, down 168.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 34.71%, down from 4.07% in the prior quarter.
- Across five years, EBIT Margin topped out at 137.29% in Q3 2025 and bottomed at 5941.67% in Q1 2022.
- The 5-year median for EBIT Margin is 34.71% (2026), against an average of 457.82%.
- The widest annual swing landed in 2022, when EBIT Margin sank 545542 bps; it then jumped 571241 bps in 2023.
- A 5-year view of EBIT Margin shows it stood at 27.49% in 2022, then tumbled by 396 bps to 81.44% in 2023, then surged by 109 bps to 7.0% in 2024, then sank by 42 bps to 4.07% in 2025, then tumbled by 952 bps to 34.71% in 2026.
- The last three EBIT Margin figures came in at 34.71% (Q1 2026), 4.07% (Q4 2025), and 137.29% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -34.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.71% |
| Dec 31, 2025 | 4.07% |
| Sep 30, 2025 | 137.29% |
| Jun 30, 2025 | -14.74% |
| Mar 31, 2025 | -49.04% |
| Dec 31, 2024 | 7.00% |
| Sep 30, 2024 | 2.27% |
| Jun 30, 2024 | -18.61% |
| Mar 31, 2024 | -53.62% |
| Dec 31, 2023 | -81.44% |
| Sep 30, 2023 | 13.12% |
| Jun 30, 2023 | -74.44% |
| Mar 31, 2023 | -229.25% |
| Dec 31, 2022 | 27.49% |
| Sep 30, 2022 | -438.83% |
| Jun 30, 2022 | -1,037.81% |
| Mar 31, 2022 | -5,941.67% |
| Dec 31, 2021 | -3,427.89% |
| Sep 30, 2021 | -3,600.68% |
| Jun 30, 2021 | -3,414.47% |
| Mar 31, 2021 | -486.25% |
| Dec 31, 2020 | -1,528.08% |
| Sep 30, 2020 | -632.55% |
| Jun 30, 2020 | -1,318.46% |
| Mar 31, 2020 | -1,794.64% |
| Dec 31, 2019 | -837.69% |
| Sep 30, 2019 | -733.12% |
| Jun 30, 2019 | -137,933.33% |
| Dec 31, 2018 | -32,207.06% |
| Sep 30, 2018 | -13,797.67% |
| Jun 30, 2018 | -73,846.67% |
| Mar 31, 2018 | -762.28% |
| Jun 30, 2015 | 49.91% |
| Mar 31, 2015 | -59.32% |
| Dec 31, 2014 | -62.05% |
| Sep 30, 2014 | 1.07% |
| Jun 30, 2014 | 30.11% |
| Mar 31, 2014 | -5.43% |
| Dec 31, 2013 | -8.46% |
| Sep 30, 2013 | -13.44% |
| Jun 30, 2013 | -11.67% |